Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial

Jane Lebkowski, Asterias Biotherapeutics’ VP of R&D, spoke to CIRM's governing Board about the company’s CIRM-funded clinical trial for spinal cord injury. Richard Lajara, the fourth participant in a previous trial, gives a patient’s perspective.

Related Links:

Disease Programs

Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.

See disease fact sheets

CIRM Stem Cell Blog